Italia markets closed

BMY Jan 2026 28.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,86000,0000 (0,00%)
Alla chiusura: 10:24AM EDT
Schermo intero
Chiusura precedente0,8600
Aperto0,8600
Denaro0,6900
Lettera0,8500
Prezzo d'esercizio28,00
Scadenza2026-01-16
Min-Max giorno0,8600 - 0,8600
Contratto - Min-MaxN/D
Volume1
Open Interest131
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri